Literature DB >> 27122576

Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.

Nicolas Noel1,2,3,4, Ruth Peña5, Annie David6, Veronique Avettand-Fenoel7,8, Itziar Erkizia5, Esther Jimenez5, Camille Lecuroux1,3, Christine Rouzioux7,8, Faroudy Boufassa9, Gianfranco Pancino10, Alain Venet1, Carine Van Lint11, Javier Martinez-Picado5,12,13, Olivier Lambotte1,2,3,4, Asier Sáez-Cirión14, Julia G Prado15.   

Abstract

UNLABELLED: HIV establishes reservoirs of infected cells that persist despite effective antiretroviral therapy (ART). In most patients, the virus begins to replicate soon after treatment interruption. However, a low frequency of infected cells at the time of treatment interruption has been associated with delayed viral rebound. Likewise, individuals who control the infection spontaneously, so-called HIV-1 controllers (HICs), carry particularly low levels of infected cells. It is unclear, however, whether and how this small number of infected cells contributes to durable viral control. Here we compared 38 HICs with 12 patients on effective combined antiretroviral therapy (cART) and found that the low frequency of infected cells in the former subjects was associated both with less efficient viral reactivation in resting CD4(+) T cells and with less efficient virion production ex vivo We also found that a potent HIV-specific CD8(+) T cell response was present only in those HICs whose CD4(+) T cells produced virus ex vivo Long-term spontaneous control of HIV infection in HICs thus appears to be sustained on the basis of the inefficient reactivation of viruses from a limited number of infected cells and the capacity of HICs to activate a potent HIV-specific CD8(+) T cell response to counteract efficient viral reactivation events. IMPORTANCE: There is a strong scientific interest in developing strategies to eradicate the HIV-1 reservoir. Very rare HIV-1-infected patients are able to spontaneously control viremia for long periods of time (HIV-1 controllers [HICs]) and are put forward as a model of HIV-1 remission. Here, we show that the low viral reservoirs found in HICs are a critical part of the mechanisms underlying viral control and result in a lower probability of HIV-1 reactivation events, resulting in limited HIV-1 release and spread. We found that those HICs in whom viral reactivation and spread from CD4(+) T cells in vitro were the most difficult were those with diminished CD8(+) T cell responses. These results suggest that, in some settings, low HIV-1 reservoirs decisively contribute to at least the temporary control of infection without antiretroviral therapy. We believe that this work provides information of relevance in the context of the search for HIV-1 remission.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27122576      PMCID: PMC4907242          DOI: 10.1128/JVI.00419-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.

Authors:  Zaza M Ndhlovu; Jacqueline Proudfoot; Kevin Cesa; Donna Marie Alvino; Ashley McMullen; Seanna Vine; Eleni Stampouloglou; Alicja Piechocka-Trocha; Bruce D Walker; Florencia Pereyra
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

2.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

4.  Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers.

Authors:  Camille Lécuroux; Asier Sáez-Cirión; Isabelle Girault; Pierre Versmisse; Faroudy Boufassa; Véronique Avettand-Fenoël; Christine Rouzioux; Laurence Meyer; Gianfranco Pancino; Olivier Lambotte; Martine Sinet; Alain Venet
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

5.  Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Authors:  Timothée Bruel; Chiraz Hamimi; Nathalie Dereuddre-Bosquet; Antonio Cosma; So Youn Shin; Aurélien Corneau; Pierre Versmisse; Ingrid Karlsson; Benoit Malleret; Brice Targat; Françoise Barré-Sinoussi; Roger Le Grand; Gianfranco Pancino; Asier Sáez-Cirión; Bruno Vaslin
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

6.  LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).

Authors:  Véronique Avettand-Fènoël; Marie-Laure Chaix; Stéphane Blanche; Marianne Burgard; Corinne Floch; Kadidia Toure; Marie-Christine Allemon; Josiane Warszawski; Christine Rouzioux
Journal:  J Med Virol       Date:  2009-02       Impact factor: 2.327

7.  Effect of antiretroviral therapy on HIV reservoirs in elite controllers.

Authors:  Tae-Wook Chun; J Shawn Justement; Danielle Murray; Connie J Kim; Jana Blazkova; Claire W Hallahan; Erika Benko; Cecilia T Costiniuk; Gabor Kandel; Mario Ostrowski; Rupert Kaul; Susan Moir; Joseph P Casazza; Richard A Koup; Colin Kovacs; Anthony S Fauci
Journal:  J Infect Dis       Date:  2013-07-11       Impact factor: 5.226

8.  Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.

Authors:  Marylyn M Addo; Rika Draenert; Almas Rathod; Cori L Verrill; Benjamin T Davis; Rajesh T Gandhi; Gregory K Robbins; Nesli O Basgoz; David R Stone; Daniel E Cohen; Mary N Johnston; Theresa Flynn; Alysse G Wurcel; Eric S Rosenberg; Marcus Altfeld; Bruce D Walker
Journal:  PLoS One       Date:  2007-03-28       Impact factor: 3.240

9.  HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription.

Authors:  Xavier Contreras; Matjaz Barboric; Tina Lenasi; B Matija Peterlin
Journal:  PLoS Pathog       Date:  2007-10-12       Impact factor: 6.823

10.  Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth.

Authors:  Maja Kiselinova; Ward De Spiegelaere; Maria Jose Buzon; Eva Malatinkova; Mathias Lichterfeld; Linos Vandekerckhove
Journal:  PLoS Pathog       Date:  2016-03-03       Impact factor: 6.823

View more
  26 in total

1.  Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.

Authors:  Caroline Pereira Bittencourt Passaes; Timothée Bruel; Jérémie Decalf; Annie David; Mathieu Angin; Valerie Monceaux; Michaela Muller-Trutwin; Nicolas Noel; Katia Bourdic; Olivier Lambotte; Matthew L Albert; Darragh Duffy; Olivier Schwartz; Asier Sáez-Cirión
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 2.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Authors:  Véronique Avettand-Fènoël; Laurent Hocqueloux; Jade Ghosn; Antoine Cheret; Pierre Frange; Adeline Melard; Jean-Paul Viard; Christine Rouzioux
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

3.  Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers.

Authors:  Xiaodong Lian; Ce Gao; Xiaoming Sun; Chenyang Jiang; Kevin B Einkauf; Kyra W Seiger; Joshua M Chevalier; Yuko Yuki; Maureen Martin; Rebecca Hoh; Michael J Peluso; Mary Carrington; Ezequiel Ruiz-Mateos; Steven G Deeks; Eric S Rosenberg; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  Sci Transl Med       Date:  2021-12-15       Impact factor: 19.319

4.  Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.

Authors:  María Pernas; Laura Tarancón-Diez; Cecilio Lopez-Galindez; Ezequiel Ruiz-Mateos; Esther Rodríguez-Gallego; Josep Gómez; Julia G Prado; Concepción Casado; Beatriz Dominguez-Molina; Isabel Olivares; Maite Coiras; Agathe León; Carmen Rodriguez; Jose Miguel Benito; Norma Rallón; Montserrat Plana; Onofre Martinez-Madrid; Marta Dapena; Jose Antonio Iribarren; Jorge Del Romero; Felipe García; José Alcamí; MaÁngeles Muñoz-Fernández; Francisco Vidal; Manuel Leal
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

5.  Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation.

Authors:  Philipp Adams; Gilles Iserentant; Jean-Yves Servais; Linos Vandekerckhove; Guido Vanham; Carole Seguin-Devaux
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

6.  Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8-11 December 2015, Miami, Florida, USA.

Authors:  David M Margolis; Karl Salzwedel; Nicolas Chomont; Christina Psomas; Jean-Pierre Routy; Guido Poli; Alain Lafeuillade
Journal:  J Virus Erad       Date:  2016-01-01

7.  Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.

Authors:  Amit Kumar; Wasim Abbas; Sophie Bouchat; Jean-Stéphane Gatot; Sébastien Pasquereau; Kabamba Kabeya; Nathan Clumeck; Stéphane De Wit; Carine Van Lint; Georges Herbein
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

8.  Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort.

Authors:  Léo Plaçais; Faroudy Boufassa; Camille Lécuroux; Elise Gardiennet; Véronique Avettand-Fenoel; Asier Saez-Cirion; Olivier Lambotte; Nicolas Noël
Journal:  EClinicalMedicine       Date:  2021-06-18

9.  Elite suppressors have low frequencies of intact HIV-1 proviral DNA.

Authors:  Abena Kr Kwaa; Caroline C Garliss; Kristen D Ritter; Gregory M Laird; Joel N Blankson
Journal:  AIDS       Date:  2020-03-15       Impact factor: 4.632

10.  Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children.

Authors:  Salvatore Rocca; Paola Zangari; Nicola Cotugno; Anita De Rossi; Bridget Ferns; Davide Petricone; Stefano Rinaldi; Carlo Giaquinto; Stefania Bernardi; Pablo Rojo; Paolo Rossi; Savita Pahwa; Eleni Nastouli; Paolo Palma
Journal:  J Pediatric Infect Dis Soc       Date:  2019-11-06       Impact factor: 5.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.